Arvinas Net Worth
Arvinas Net Worth Breakdown | ARVN |
Arvinas Net Worth Analysis
Arvinas' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Arvinas' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Arvinas' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Arvinas' net worth analysis. One common approach is to calculate Arvinas' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Arvinas' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Arvinas' net worth. This approach calculates the present value of Arvinas' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Arvinas' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Arvinas' net worth. This involves comparing Arvinas' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Arvinas' net worth relative to its peers.
Enterprise Value |
|
To determine if Arvinas is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Arvinas' net worth research are outlined below:
| Arvinas had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 78.5 M. Net Loss for the year was (367.3 M) with profit before overhead, payroll, taxes, and interest of 131.4 M. | |
| Arvinas currently holds about 1.27 B in cash with (347.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 23.87. | |
| Arvinas has a poor financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference |
Arvinas uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Arvinas. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Arvinas' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Arvinas' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Arvinas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arvinas backward and forwards among themselves. Arvinas' institutional investor refers to the entity that pools money to purchase Arvinas' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 M | Geode Capital Management, Llc | 2024-09-30 | 1.5 M | Avidity Partners Management Lp | 2024-09-30 | 1.5 M | New Leaf Venture Partners, L.l.c. | 2024-09-30 | 1.4 M | Nextech Invest Ag | 2024-09-30 | 1.4 M | Braidwell Lp | 2024-09-30 | 1.3 M | Opaleye Management Inc | 2024-09-30 | 1.3 M | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 1.2 M | Commodore Capital Lp | 2024-09-30 | 1.2 M | Vanguard Group Inc | 2024-09-30 | 7 M | Ecor1 Capital, Llc | 2024-09-30 | 6.7 M |
Follow Arvinas' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.79 B.Market Cap |
|
Project Arvinas' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.38) | (0.40) | |
| Return On Assets | (0.28) | (0.30) | |
| Return On Equity | (0.56) | (0.58) |
When accessing Arvinas' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Arvinas' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Arvinas' profitability and make more informed investment decisions.
Evaluate Arvinas' management efficiency
Arvinas has return on total asset (ROA) of (0.2007) % which means that it has lost $0.2007 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5916) %, meaning that it created substantial loss on money invested by shareholders. Arvinas' management efficiency ratios could be used to measure how well Arvinas manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.3. In addition to that, Return On Capital Employed is likely to drop to -0.4. At this time, Arvinas' Non Currrent Assets Other are very stable compared to the past year. As of the 28th of November 2024, Fixed Asset Turnover is likely to grow to 5.73, while Total Assets are likely to drop about 753.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 11.89 | 7.71 | |
| Tangible Book Value Per Share | 11.89 | 7.71 | |
| Enterprise Value Over EBITDA | (5.00) | (5.25) | |
| Price Book Value Ratio | 3.46 | 3.29 | |
| Enterprise Value Multiple | (5.00) | (5.25) | |
| Price Fair Value | 3.46 | 3.29 | |
| Enterprise Value | 2.5 B | 2.6 B |
The leadership approach at Arvinas' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 3.4885 | Revenue 161.1 M | Quarterly Revenue Growth 1.96 | Revenue Per Share 2.327 | Return On Equity (0.59) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arvinas insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arvinas' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arvinas insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arvinas Corporate Filings
8K | 19th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 27th of June 2024 Other Reports | ViewVerify | |
F3 | 26th of June 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Arvinas Earnings per Share Projection vs Actual
Arvinas Corporate Management
| CPA CPA | CFO Treasurer | Profile | |
| Ian Taylor | Chief Scientific Officer | Profile | |
| Paul McInulty | Senior Affairs | Profile | |
| Matthew JD | Gen Sec | Profile | |
| John Grosso | Senior Operations | Profile | |
| Randy Teel | Senior Development | Profile |
Already Invested in Arvinas?
The danger of trading Arvinas is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arvinas is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arvinas. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arvinas is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.79) | Revenue Per Share 2.327 | Quarterly Revenue Growth 1.96 | Return On Assets (0.20) | Return On Equity (0.59) |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.